Johan Van Eldere

Johan Van Eldere publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Johan Van Eldere sits on this spectrum.

Johan Van Eldere D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Johan Van Eldere sits on this spectrum.

Best Publications

• Galactomannan and Computed Tomography–Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study

  Johan Maertens;Koen Theunissen;Gregor Verhoef;Johnny Verschakelen

  828
  Citations

• Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.

  N Mesaros;P Nordmann;P Plesiat;M Roussel-Delvallez

  811
  Citations

• Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

  Johan Maertens;Jan Verhaegen;Katrien Lagrou;Johan Van Eldere

  744
  Citations

• Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis

  Johan Maertens;Jan Verhaegen;Hilde Demuynck;Penelope Brock

  539
  Citations

• Use of Circulating Galactomannan Screening for Early Diagnosis of Invasive Aspergillosis in Allogeneic Stem Cell Transplant Recipients

  Johan Maertens;Johan Van Eldere;Jan Verhaegen;Erik Verbeken

  480
  Citations

• High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial.

  An Lehouck;Chantal Mathieu;Claudia Carremans;Femke Baeke

  473
  Citations

• Otitis media and its consequences: beyond the earache

  Anne Vergison;Ron Dagan;Adriano Arguedas;Jan Bonhoeffer

  412
  Citations

• Non-typeable Haemophilus influenzae, an under-recognised pathogen.

  Johan Van Eldere;Johan Van Eldere;Mary P E Slack;Shamez Ladhani;Allan W Cripps

  364
  Citations

• Pseudomonas aeruginosa population structure revisited

  Jean-Paul Pirnay;Florence Bilocq;Bruno Pot;Pierre Cornelis

  322
  Citations

• Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases

  Johan Maertens;Vincent Maertens;Koen Theunissen;Wouter Meersseman

  298
  Citations

• Antibacterial and antifungal properties of α-helical, cationic peptides in the venom of scorpions from southern Africa

  Leentje Moerman;Suzanne Bosteels;Wim Noppe;Jean Willems

  260
  Citations

• Optimization of the Cutoff Value for the Aspergillus Double-Sandwich Enzyme Immunoassay

  Johan A. Maertens;Rocus Klont;Christine Masson;Koen Theunissen

  241
  Citations

• Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients.

  Johan Maertens;Koen Theunissen;Eric Verbeken;Katrien Lagrou

  232
  Citations

• Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river

  Jean-Paul Pirnay;Sandra Matthijs;Huri Colak;Patrice Chablain

  194
  Citations

• Quantification of Expression of <i>Staphylococcus epidermidis</i> Housekeeping Genes with Taqman Quantitative PCR during In Vitro Growth and under Different Conditions

  Unknown

  168
  Citations

• Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients.

  Johan Maertens;Kristel Buvé;Koen Theunissen;Wouter Meersseman

  163
  Citations

• Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections

  Unknown

  163
  Citations

• Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial).

  Unknown

  163
  Citations

• Serum (1-3)-β-d-Glucan as a Tool for Diagnosis of Pneumocystis jirovecii Pneumonia in Patients with Human Immunodeficiency Virus Infection or Hematological Malignancy

  Stefanie Desmet;Eric Van Wijngaerden;Johan Maertens;Jan Verhaegen

  140
  Citations

• Candida albicans biofilm formation in a new in vivo rat model.

  Markéta Řičicová;Soňa Kucharíková;Soňa Kucharíková;Hélène Tournu;Jelle Hendrix

  130
  Citations